Literature DB >> 28428936

Multistate Models on Pleural Effusion after Allogeneic Hematopoietic Stem Cell Transplantation.

Joohyoung Lee1,2, Dipenkumar Modi3, Hyejeong Jang2,4, Joseph P Uberti4, Seongho Kim2,4.   

Abstract

A multistate model is more complicated than competing risk models and composed of finite number of states and transitions between states. Unlike competing risk models, this model has the ability to assess the effect of occurrence order of time-to-event data. Pleural effusion (PE) is a severe complication that often occurs after allogeneic hematopoietic stem cell transplantation (HSCT). Many patients develop pleural effusion during the first 100 days after allogeneic HSCT and graft-versus-host disease (GVHD) occurs either before or after the development of PE, implying that the occurrence order of PE and GVHD (i.e., PE after GVHD vs. GVHD after PE) would influence on the incidence, risk factors and mortality of pleural effusion. One can use either Cox proportional models or competing risk models to evaluate these values, but neither method is able to incorporate the occurrence order of incidence into the model. To resolve this difficulty, we developed a multistate model describing several possible events and event-related dependences and applied to a retrospective study of 606 patients, including eight covariates.

Entities:  

Keywords:  Cox proportional model; Hematopoietic stem cell transplantation; Multistate model; Pleural effusion; Survival analysis

Year:  2017        PMID: 28428936      PMCID: PMC5394937          DOI: 10.2147/OAMS.S125465

Source DB:  PubMed          Journal:  Open Access Med Stat        ISSN: 2230-3251


  12 in total

1.  The pulmonary complications of bone marrow transplantation in adults.

Authors:  P W Noble
Journal:  West J Med       Date:  1989-04

2.  Sample size calculations in the presence of competing risks.

Authors:  A Latouche; R Porcher
Journal:  Stat Med       Date:  2007-12-30       Impact factor: 2.373

3.  Incidence, etiology, and outcome of pleural effusions in allogeneic hematopoietic stem cell transplantation.

Authors:  Dipenkumar Modi; Hyejeong Jang; Seongho Kim; Abhinav Deol; Lois Ayash; Divaya Bhutani; Lawrence G Lum; Voravit Ratanatharathorn; Richard Manasa; Kendra Mellert; Joseph P Uberti
Journal:  Am J Hematol       Date:  2016-07-14       Impact factor: 10.047

4.  The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models.

Authors:  Liesbeth C de Wreede; Marta Fiocco; Hein Putter
Journal:  Comput Methods Programs Biomed       Date:  2010-03-15       Impact factor: 5.428

5.  Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation.

Authors:  Shernan G Holtan; Todd E DeFor; Aleksandr Lazaryan; Nelli Bejanyan; Mukta Arora; Claudio G Brunstein; Bruce R Blazar; Margaret L MacMillan; Daniel J Weisdorf
Journal:  Blood       Date:  2015-01-15       Impact factor: 22.113

6.  Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

Authors:  Koen van Besien; Fausto R Loberiza; Ruta Bajorunaite; James O Armitage; Asad Bashey; Linda J Burns; Cesar O Freytes; John Gibson; Mary M Horowitz; David J Inwards; David I Marks; Rodrigo Martino; Richard T Maziarz; Arturo Molina; Santiago Pavlovsky; Andrew L Pecora; Harry C Schouten; Thomas C Shea; Hillard M Lazarus; J Douglas Rizzo; Julie M Vose
Journal:  Blood       Date:  2003-07-31       Impact factor: 22.113

7.  Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome.

Authors:  M F Ozkaynak; K Weinberg; D Kohn; L Sender; R Parkman; C Lenarsky
Journal:  Bone Marrow Transplant       Date:  1991-06       Impact factor: 5.483

8.  Multi-state analysis illustrates treatment success after stem cell transplantation for acute myeloid leukemia followed by donor lymphocyte infusion.

Authors:  Matthias Eefting; Liesbeth C de Wreede; Constantijn J M Halkes; Peter A von dem Borne; Sabina Kersting; Erik W A Marijt; Hendrik Veelken; Hein Putter; Johannes Schetelig; J H Frederik Falkenburg
Journal:  Haematologica       Date:  2016-01-22       Impact factor: 9.941

9.  Competing risks and multistate models.

Authors:  Claudia Schmoor; Martin Schumacher; Jürgen Finke; Jan Beyersmann
Journal:  Clin Cancer Res       Date:  2012-11-21       Impact factor: 12.531

Review 10.  Review of multistate models in hematopoietic cell transplantation studies.

Authors:  Brent R Logan
Journal:  Biol Blood Marrow Transplant       Date:  2012-10-17       Impact factor: 5.742

View more
  1 in total

1.  Relaxing the assumption of constant transition rates in a multi-state model in hospital epidemiology.

Authors:  Micki Hill; Paul C Lambert; Michael J Crowther
Journal:  BMC Med Res Methodol       Date:  2021-01-11       Impact factor: 4.615

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.